90536-91-7

Usage

Uses

Used in Pharmaceutical Industry:
1-PIPERIDIN-4-YL-1,3-DIHYDRO-2H-INDOL-2-ONE is used as a key intermediate in the synthesis of various pharmaceutical drugs and organic compounds due to its unique molecular structure and versatile chemical properties. Its ability to be integrated into complex molecular frameworks makes it instrumental in the development of new therapeutic agents.
Used in Cancer Research:
In the field of oncology, PDI is utilized as a potential therapeutic agent for the treatment of various types of cancer. Its pharmacological properties are being studied for their ability to target and combat cancer cells, offering a new avenue for cancer treatment strategies.
Used in Neurological Disorders Research:
PDI is also being explored for its potential in treating neurological disorders. Its capacity to interact with specific biological targets in the nervous system positions it as a candidate for the development of drugs aimed at alleviating symptoms and potentially curing such conditions.
Used in Drug Development:
As a promising candidate for further research and development, PDI is employed in the advancement of pharmaceuticals, where its unique attributes can be leveraged to create novel drugs with improved efficacy and safety profiles for a range of medical conditions.